Gastroesophageal Reflux Disease Clinical Trial
Official title:
i-Scan Endoscopy in the Detection of Minimal Change Esophagitis in Dyspeptic Patients With or Without Gastroesophageal Reflux Disease by Gerd Q Questionnaire and by 24 Hour pH Monitoring.
The purpose of this study to assess efficacy of SE endoscopy in the detection of MCE in dyspeptic patients with or without GERD diagnosed by GerdQ or by endoscopy + PHM and in normal volunteers.
Background: The association of minimal change esophagitis (MCE) with gastroesophageal reflux
(GERD) is controversy. High resolution endoscopy may improve the detection of minimal change
lesion (MCL). i- Scan endoscopy (SE) provides high resolution images with modulation of
images for a specific purpose.
Methods. All dyspeptic patients with or without GERD symptoms scheduled for endoscopy were
recruited from February 2010 till July 2014. All completed the validated Thai version of
GerdQ then underwent endoscopy. Forty normal volunteers were recruited for endoscopy and PHM
test. The esophagus was examined by HD and SE with the TE-e mode sequentially. The captured
images were independently evaluated for MCL (punctate erythema (PE), minute erosion (ME) and
triangular lesion with elongated pit (EP) by three endoscopists. The agreement of > 2
endoscopists was accepted as a final result. All had PHM within 1 week after the endoscopy.
GERD was diagnosed by LA grade A-D esophagitis and/or PHM with acid exposure time > the
upper limit of volunteer and/or positive symptom index and/or positive Symptom Association
Probability. MCE was diagnosed when PE, ME or EP or the combination of these were present.
The 40 normal volunteers were recruited for performing pH monitoring. The PHM data of 40
volunteers were analyzed to set the upper normal limit of total acid exposure time in our
population. The mean + 2SD of total acid exposure time of volunteers was 1.9%.
Definition. GerdQ. The Thai version of GerdQ was translated from the English version. The
contents of the GerdQ were tested by back translation from Thai to English by 5 personnel
who are fluent in English and all showed the consistent contents. The reliability of the
GerdQ was validated in 22 volunteers completing the questionnaire twice with 3 hours in
between and showed no significant difference of the mean score (5.14+ 2.34 vs 6.23+ 1.57,
p=0.07) and the number of subjects with GERD diagnosed by the GerdQ (2 vs 5, Fisher's extact
test, p=0.21) .
GERD is diagnosed when total acid exposure time is more than 2% or positive symptom index
(SI) or positive symptom association probability ( SAP ) or endoscopy revealed LA erosive
esophagitis > grade A.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02135107 -
A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients
|
Phase 3 | |
Completed |
NCT01432392 -
Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
|
N/A | |
Recruiting |
NCT01249482 -
Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
|
N/A | |
Completed |
NCT01200550 -
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
|
N/A | |
Completed |
NCT01578642 -
Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease
|
Phase 2 | |
Completed |
NCT00998244 -
Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease
|
N/A | |
Unknown status |
NCT01128608 -
The Effect of High PCO2 Solution on Esophageal Acid Sensation
|
N/A | |
Completed |
NCT00978016 -
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)
|
Phase 2 | |
Completed |
NCT00768443 -
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
|
N/A | |
Completed |
NCT00768196 -
Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients
|
N/A | |
Recruiting |
NCT00498082 -
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
|
N/A | |
Completed |
NCT00886197 -
Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT00378898 -
Feasibility of Placing Bravo PH Capsule in Proximal Esophagus
|
N/A | |
Completed |
NCT00507377 -
Foreshortened Esophagus and Its Surgical Therapy
|
||
Completed |
NCT00217347 -
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy
|
N/A | |
Completed |
NCT00165022 -
Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population
|
N/A | |
Completed |
NCT00625495 -
Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
|
Phase 4 | |
Completed |
NCT00214552 -
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
|
Phase 3 | |
Completed |
NCT00618150 -
Patient Education in Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT03299985 -
Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease
|
N/A |